Ayala Pharmaceuticals, Inc.
Pharmaceutical company · Monmouth Junction, New Jersey, United States
Ayala Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Monmouth Junction, New Jersey, United States. It has reported private securities offerings to the US SEC, most recently $433,825 sold in a notice filed in 2023.
Ayala Pharmaceuticals at a glance
What does Ayala Pharmaceuticals do?
Private fundraising reported to the SEC
14 Form D notices; the most recent reported $433,825 sold (2023).
Frequently asked questions about Ayala Pharmaceuticals
Where is Ayala Pharmaceuticals headquartered?
Ayala Pharmaceuticals, Inc. is headquartered in Monmouth Junction, New Jersey, United States.
What does Ayala Pharmaceuticals do?
Ayala Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Tris Pharma, Inc.Monmouth Junction, New Jersey, United States
- Taxis Pharmaceuticals, Inc.Monmouth Junction, New Jersey, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences